• Home
  • Synthaverse S.A.

Synthaverse S.A.

About Synthaverse S.A.

We are a Polish pharmaceutical company with almost 100 years of tradition, and constantly looking for new ways of development. Many years of experience and achievements of the company are the best proof of our commitment, the beneficiaries of which are our business partners and patients themselves.
Our goal is to create an effective, modern and dynamically developing organization in the Life ...

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Poland
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • +48815338221
  • 10 Uniwersytecka Street, 20-029, Lublin, Poland
Show contact info Hide contact info

Products from Synthaverse S.A. (3)

  • Anti-tuberculosis vaccine BCG10

    Product Anti-tuberculosis vaccine BCG10

    BCG 10 Anti-Tuberculosis Vaccine is used for protective vaccinations against tuberculosis. Catch-up (supplementary) vaccinations in subjects unvaccinated after birth should be performed as early as possible, no later than at 15 years of age. In case of BCG immunisation booster vaccine doses are not recomme...
  • BCG10 anti-tuberculosis vaccine

    Product BCG10 anti-tuberculosis vaccine

    Freeze-dried powder of live attenuated BCG bacilli, the Brazilian Moreau substrain, for suspension for intradermal injection. 5 ampoules with powder and 5 ampoules with solvent, 1 ml each. 0.1 ml for one child, 1 ampoule – 10 vaccinations, 1 pack – 50 vaccinations
  • Distreptaza

    Product Distreptaza

    Supportive treatment of pelvic inflammatory disease (PID) – inflammatory diseases of the ovaries, fallopian tubes and endometrium. Adhesions after abdominal surgical procedures. Acute haemorrhoidal disease and chronic haemorrhoidal disease. As a supportive treatment in perirectal abscesses and ...

Synthaverse S.A. Resources (1)